Vindesine induces rhabdomyolysis in patients with acute lymphoblastic leukemia.

Author: Limin LIU ¹ ; Yumei SUN ¹ ; Yejun SI ¹ ; Guoqiang LIN ¹ ; Xingxia ZHANG ¹ ; Guangsheng ZHAO ¹ ; Yanming ZHANG ² ; Depei WU ³
Author Information

1. Department of Hematology, Huai'an Hospital Affiliated to Xuzhou Medical College and Huai'an Second People's Hospital, Huai'an, Jiangsu 223002, China.
2. Department of Hematology, Huai'an Hospital Affiliated to Xuzhou Medical College and Huai'an Second People's Hospital, Huai'an, Jiangsu 223002, China. Email: zhangyanming2005@126.com.
3. First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, China.
Publication Type:Case Reports
MeSH: Adult; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; drug therapy; Rhabdomyolysis; chemically induced; diagnosis; Vindesine; adverse effects; therapeutic use
From: Chinese Medical Journal 2014;127(21):3835-3836
CountryChina
Language:English